We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Amneal Pharmaceuticals
AMRX
$5.72B
| $597K | ﹤0.01% |
153,753
-23,490
| -13% | -$100K |
|
2202
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $597K | ﹤0.01% |
10,396
-5,495
| -35% | -$313K |
|
2203
Waterstone Financial
WSBF
$374M
| $597K | ﹤0.01% |
38,534
-5,294
| -12% | -$79.4K |
|
|
CMRC
2204
Commerce.com Inc Series 1
CMRC
$176M
| $596K | ﹤0.01% |
+7,157
| New | +$626K |
|
2205
Bank of Marin Bancorp
BMRC
$455M
| $595K | ﹤0.01% |
20,557
-2,857
| -12% | -$89.8K |
|
2206
OrthoPediatrics
KIDS
$602M
| $594K | ﹤0.01% |
12,926
-1,850
| -13% | -$85.8K |
|
2207
Univest Financial
UVSP
$1.17B
| $594K | ﹤0.01% |
41,347
-9,928
| -19% | -$154K |
|
|
OSH
2208
DELISTED
Oak Street Health, Inc.
OSH
| $593K | ﹤0.01% |
+11,103
| New | +$497K |
|
2209
Korro Bio
KRRO
$198M
| $592K | ﹤0.01% |
616
-116
| -16% | -$125K |
|
2210
Krystal Biotech
KRYS
$9.74B
| $589K | ﹤0.01% |
13,675
-1,520
| -10% | -$66K |
|
2211
Rayonier Advanced Materials
RYAM
$603M
| $589K | ﹤0.01% |
184,025
+6,873
| +4% | +$22.2K |
|
2212
Option Care Health
OPCH
$3.67B
| $586K | ﹤0.01% |
43,813
-2,680
| -6% | -$32.6K |
|
2213
Sterling Infrastructure
STRL
$16.6B
| $586K | ﹤0.01% |
41,349
-4,089
| -9% | -$51.4K |
|
2214
Carriage Services
CSV
$561M
| $585K | ﹤0.01% |
26,217
-3,870
| -13% | -$81.4K |
|
2215
UNIFI
UFI
$133M
| $583K | ﹤0.01% |
45,369
-2,931
| -6% | -$36.6K |
|
|
AERI
2216
DELISTED
Aerie Pharmaceuticals
AERI
| $583K | ﹤0.01% |
49,504
-13,847
| -22% | -$169K |
|
2217
Hyster-Yale Materials Handling
HY
$652M
| $582K | ﹤0.01% |
15,668
-2,123
| -12% | -$83.6K |
|
2218
Barrett Business Services
BBSI
$787M
| $581K | ﹤0.01% |
44,280
-6,000
| -12% | -$82.1K |
|
2219
Red Robin
RRGB
$151M
| $579K | ﹤0.01% |
44,000
+1,733
| +4% | +$18.1K |
|
2220
Ecovyst
ECVT
$1.12B
| $577K | ﹤0.01% |
56,246
-7,815
| -12% | -$95.3K |
|
2221
Protagonist Therapeutics
PTGX
$9.68B
| $576K | ﹤0.01% |
29,446
-230
| -0.8% | -$4.32K |
|
|
CLVS
2222
DELISTED
Clovis Oncology, Inc.
CLVS
| $574K | ﹤0.01% |
98,481
-17,617
| -15% | -$105K |
|
|
JAMF
2223
DELISTED
Jamf
JAMF
| $572K | ﹤0.01% |
+15,203
| New | +$571K |
|
|
FFIC
2224
DELISTED
Flushing Financial
FFIC
| $568K | ﹤0.01% |
54,028
-5,759
| -10% | -$65.3K |
|
2225
Kosmos Energy
KOS
$1.5B
| $568K | ﹤0.01% |
582,411
-87,245
| -13% | -$128K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.